Streetbeat News

Revenues

VZ

Goldman Sachs analyst James Schneider maintained a Buy rating on Verizon with a price target of $52. Verizon's Q3 results were in line with expectations, with revenue slightly below consensus. The company reaffirmed its 2024 guidance, and investor focus is expected to shift to its broadband strategy.

Portfolio Pulse from Anusuya Lahiri

October 22, 2024 | 6:08 pm

TTWO

Analysts have mixed views on Take-Two Interactive (NASDAQ:TTWO) with a majority being bullish. Recent evaluations show a slight increase in the average 12-month price target to $191.73. Despite positive revenue growth, the company faces challenges with profitability and asset returns.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 6:05 pm

SHAK

Shake Shack (NYSE:SHAK) has received mixed analyst ratings over the past three months, with a recent average price target of $114.07, reflecting a 3.51% increase. Analysts have varied in their ratings, with some raising and others lowering their price targets. Shake Shack has shown strong revenue growth but faces challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 6:05 pm

UNH

The article discusses recent analyst ratings for UnitedHealth Group (NYSE:UNH), highlighting a mix of bullish and somewhat bullish perspectives. Analysts have set a 12-month average price target of $616.94, with a high of $675.00 and a low of $591.00. Recent actions include both raises and lowers in ratings and price targets by various analysts. UnitedHealth Group shows strong financial performance with a solid revenue growth rate, high net margin, and impressive ROE and ROA, but faces challenges with a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 6:05 pm

GNRC

Generac Holdings (NYSE:GNRC) has received a range of analyst ratings over the past three months, with a notable increase in the average 12-month price target to $175.88. Analysts have shown a mix of bullish and neutral sentiments, with several raising their price targets. Despite a slight decline in revenue growth, Generac's financial metrics like net margin, ROE, and ROA remain strong, indicating effective cost management and financial health.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 6:05 pm

KVUE

Analysts have provided diverse evaluations of Kenvue (NYSE:KVUE) over the past three months, with a mix of bullish and somewhat bullish ratings. The average 12-month price target has increased to $24.1. Kenvue, a leading consumer health company, faces challenges with a slight revenue decline but maintains strong financial metrics like net margin and ROE.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 6:04 pm

CBUS

Analysts have provided mixed ratings for Cibus (NASDAQ:CBUS) over the past three months, with a majority maintaining a bullish outlook. The average 12-month price target is $21.9, slightly down from $22.00. Cibus has shown significant revenue growth but faces challenges with profitability.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 6:02 pm

RCL

Analysts have shown a positive shift in sentiment towards Royal Caribbean Gr (NYSE:RCL) over the past quarter, with several raising their price targets. The average 12-month price target has increased by 15.3% to $204.17. The company shows strong financial performance with high revenue growth and profitability, but faces challenges with high debt levels.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 6:01 pm

PFGC

Analysts have shown a positive sentiment towards Performance Food Group (NYSE:PFGC) with several raising their price targets. The average 12-month price target is now $90.11, reflecting a 5.6% increase. The company has shown revenue growth but faces challenges in net margin and ROE.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 6:01 pm

GEVO

Gevo (NASDAQ:GEVO) has been analyzed by four financial analysts, showing a range of opinions from bullish to bearish. The average 12-month price target has increased by 5.6% to $11.31. Analysts have maintained or raised their ratings, with a high target of $14.00 and a low of $3.25. Gevo's financial performance shows revenue growth but challenges in profitability and returns.

Portfolio Pulse from Benzinga Insights

October 22, 2024 | 6:01 pm